Cannabis Tax Changes Could Trigger 504% Cash Flow Leap, Which Industry Players Will Benefit?
The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the
EXCLUSIVE: Tesla Lowers Prices In China Because It Can, Not Because It Has To, Says Cathie Wood
Tesla's Chinese strategy forms a critical aspect of its global vision, Cathie Wood notes during "The Raz Report" interview.
EXCLUSIVE: Cathie Wood’s Sports Betting Gamble — DraftKings Or Penn Entertainment?
The sports betting world was shocked in August when PENN Entertainment (NASDAQ: PENN) announced a licensing deal with The Walt Disney Company (NYSE: DIS) to launch
EXCLUSIVE: Lancaster Resources to Acquire Lithium Project in Quebec’s Prolific James Bay Region
Lancaster Resources Inc (OTC: LANRF) on August 29, 2023, agreed to replace the Letter of Intent entered into on July 23, 2023 to acquire 100% of the Trans Taiga Lithium Project (Property) in the Eeyou Istchee James Bay region of Quebec.
EXCLUSIVE – Federal Agency Calls For Relaxed Marijuana Laws: Experts Explain What This Means
In a pivotal move that could reshape the federal stance on marijuana, a top official at the Department of Health and Human Services (HHS) has recommended that the substance be reclassified as a Schedule III substance under the Controlled Substances Act.
EXCLUSIVE: Cathie Wood Flips The Script, Warns Of Looming Deflation
While many investors and economists are preoccupied with the specter of inflation, Ark Invest founder Cathie Wood is…
EXCLUSIVE: Cathie Wood Tells Benzinga Why Tesla Should Trade As A Tech Stock
Electric vehicle leader Tesla Inc (NASDAQ: TSLA) is one of the best-performing stocks of the last five years, up over 1,000%.
EXCLUSIVE: Watch Cathie Wood Predict SEC’s Loss In Bitcoin ETF Case In Benzinga Interview
Shares of cryptocurrency companies rocketed higher Wednesday on the heels of a historic ruling in Grayscale Investments' lawsuit against the Securities and Exchange Commission.
EXCLUSIVE: Diagnostics Provider Avalon GloboCare’s Subsidiary Launches New Laboratory Test For Tuberculosis
Avalon GloboCare Corp (NASDAQ: ALBT) announced that Laboratory Services MSO (LSM) is now offering an in-house laboratory-developed test to detect tuberculosis using a patient’s sputum sample.
Avalon owns a 40% interest in Laboratory Services (LSM).
EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
Alzamend Neuro Inc (NASDAQ: ALZN) has submitted an investigational new drug (IND) application to the FDA to initiate AL001-BD01, a Phase 2A study of AL001 for bipolar disorder.